fda update on semaglutide As of February 21, 2025, the updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA Warns on Certain Forms

We prescribe Ipamorelin (combined with CJC-1295) and Tesamorelin instead, because both produce stronger, more sustained, more selective growth hormone results than Sermorelin alone

Injecting air into the vial while drawing bacteriostatic water creates positive pressure that forces liquid back through the needle during withdrawal

And were seeing about 50% of patients regain weight after stopping therapy and a disbelief among patients that this is something they can control. Insurance coverage (or lack thereof) may also present a challenge to sustaining weight loss results

If you want to change the world, start with yourself and then share that experience and say, Look, I love you and I want you to be around and Im changing myself and I want you to join me